Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahmed S. S., Jaferi G. A., Narang R. M., Regan T. J. Preclinical abnormality of left ventricular function in diabetes mellitus. Am Heart J. 1975 Feb;89(2):153–158. doi: 10.1016/0002-8703(75)90039-3. [DOI] [PubMed] [Google Scholar]
- Feinstein A. R. Clinical biostatistics. 8. An analytic appraisal of the University Group Diabetes Program (UGDP) study. Clin Pharmacol Ther. 1971 Mar-Apr;12(2):167–191. doi: 10.1002/cpt1971122part1167. [DOI] [PubMed] [Google Scholar]
- Garcia M. J., McNamara P. M., Gordon T., Kannel W. B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974 Feb;23(2):105–111. doi: 10.2337/diab.23.2.105. [DOI] [PubMed] [Google Scholar]
- Hamby R. I., Zoneraich S., Sherman L. Diabetic cardiomyopathy. JAMA. 1974 Sep 23;229(13):1749–1754. [PubMed] [Google Scholar]
- Lasseter K. C., Levey G. S., Palmer R. F., McCarthy J. S. The effect of sulfonylurea drugs on rabbit myocardial contractility, canine purkinje fiber automaticity, and adenyl cyclase activity from rabbit and human hearts. J Clin Invest. 1972 Sep;51(9):2429–2434. doi: 10.1172/JCI107056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MOWRY R. W., BANGLE R., Jr Histochemically demonstrable glycogen in the human heart, with special reference to glycogen storage disease and diabetes mellitus. Am J Pathol. 1951 Jul-Aug;27(4):611–625. [PMC free article] [PubMed] [Google Scholar]
- Scheuer J., Stezoski S. W. Protective role of increased myocardial glycogen stores in cardiac anoxia in the rat. Circ Res. 1970 Nov;27(5):835–849. doi: 10.1161/01.res.27.5.835. [DOI] [PubMed] [Google Scholar]
- Soler N. G., Bennett M. A., Pentecost B. L., Fitzgerald M. G., Malins J. M. Myocardial infarction in diabetics. Q J Med. 1975 Jan;44(173):125–132. [PubMed] [Google Scholar]
- Soler N. G., Pentecost B. L., Bennett M. A., FitzGerald M. G., Lamb P., Malins J. M. Coronary care for myocardial infarction in diabetics. Lancet. 1974 Mar 23;1(7856):475–477. doi: 10.1016/s0140-6736(74)92785-8. [DOI] [PubMed] [Google Scholar]
- Tzagournis M., Reynertson R. Mortality from coronary heart disease during phenformin therapy. Ann Intern Med. 1972 Apr;76(4):587–592. doi: 10.7326/0003-4819-76-4-587. [DOI] [PubMed] [Google Scholar]
